Find the right fit for you - faster
Get tailored insights about working at Fulcrum Pharma in one quick step.
Fulcrum Pharma Snapshot
Fulcrum Pharma's business is pivoted on developing drugs. Its focus is on clinical regulatory business, drug development strategy, early-stage development, pre-clinical assessment, and regulatory services through its eight offices in Europe, Japan, and the US. The company was formed in 1999 by a group of executives formerly with Hoffman-La Roche's subsidiary Protodigm. Fulcrum Pharma was taken private by SV Life Sciences and private equity firm Halifax Group in 2010. It was then rolled up with five other companies to create Aptiv Solutions, a biopharmaceutical and medical device development services group. Fulcrum Pharma operates independently within Aptiv Solutions.
